Parker-Hannifin Corporation (NYSE: PH) — A Genuinely Better Business, Priced as Though Both Its Cycles Peak Forever

Independent equity research Report date: 2026-06-13 Price (2026-06-12): $903.48 · Market cap: ~$114B · Enterprise value: ~$123B · Shares: ~126.1M Fiscal year: ends June 30 (FY2025 = year ended 2025-06-30)

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows takes no position, carries no recommendation, and contains no price target except where this block explicitly states one.

Verdict: HOLD / “great business, wrong price.” Accumulate only on weakness — a buyer’s zone opens roughly in the high-$600s to mid-$700s (~22–26x forward adjusted EPS); at ~$900 (~29x forward / ~33x trailing / ~23x EV/EBITDA) the burden of proof sits squarely on the bull. Not a short — the quality is real and the order book is at a record.

Parker-Hannifin is a materially better company than the hydraulics-and-fittings cyclical it was a decade ago. The Meggitt acquisition tripled a genuinely high-quality aerospace aftermarket annuity; the Win Strategy operating system has roughly doubled segment margins to ~23% and — crucially — held them through a two-year industrial down-cycle; and the distribution network underpinning half of industrial revenue is the one asset competitors cannot quickly replicate. This is a real moat that shows up in real numbers: ~26% ROE, ~17% all-in ROIC on a goodwill-heavy balance sheet, ~17% FCF margins. None of that is in dispute. What I dispute is the price. At ~33x trailing and ~29x forward earnings — the 95th–96th percentile of PH’s own ten-year history — the market is paying a secular-compounder multiple at the precise moment PH’s two profit engines may both be near cyclical highs: aerospace segment margins just printed a record 29.5%, while the industrial multiple for the entire group (ETN, AME, DOV, PH) has re-rated to a level historically associated with peaks. A reverse-DCF says the stock embeds ~12% FCF growth for a decade from a 4–6% organic grower. That is a margin-of-safety-free setup: my base case (FY2029 targets met) returns only a market-like ~6%/yr because so much is already in the price, while a multiple de-rate toward a still-premium 20x with any earnings stumble is a 20–35% drawdown. The framing is quality-compounder-at-the-wrong-entry-point, not value and not momentum-chase.

Conviction: medium. What flips me bullish: clear evidence that the 29.5% aero margin is a durable base (not a mix/cycle peak) and an industrial short-cycle volume inflection converting the record $12.5B backlog into accelerating organic growth — two cyclical highs proven sustainable simultaneously. What flips me bearish: aero margins rolling off the peak, the industrial restock failing to arrive, or the $9.25B Filtration Group deal (bought at a full 19.6x EBITDA, levering to ~3.0x) slipping on synergies while consuming the buyback/M&A flexibility the multiple assumes. Tag: “Two peaks, one price — wait for the air pocket.”

1. Executive Summary

Parker-Hannifin is the global leader in motion-and-control technologies — an ~$20B-revenue, Cleveland-based diversified industrial and aerospace manufacturer operating across eight core technologies (hydraulics, pneumatics, electromechanical, filtration, fluid & gas handling, process control, engineered materials, climate control) sold to OEMs and, critically, through an independent distributor network that has taken 60-plus years to build. It reports two segments: Diversified Industrial (~69% of FY2025 sales) and Aerospace Systems (~31%).

The investment story is a genuine business-quality transformation colliding with a full valuation. Over a decade, the Win Strategy operating system has roughly doubled segment operating margins to ~23%; the Meggitt acquisition (September 2022, ~$8.8B) tripled the aerospace franchise and converted it from a 12.9%-margin integration drag (FY2023) into a record 29.5%-margin annuity engine (Q3 FY2026); and a deliberate portfolio shift toward longer-cycle, secular and aftermarket revenue has made the company structurally less cyclical. The financial signature is high quality: FY2025 revenue $19.85B, operating margin 21.9%, free cash flow $3.34B (16.8% margin), ROE ~26%, and a balance sheet deleveraged from ~$11.7B to ~$8.8B net debt in the three years after Meggitt. Management has raised FY2026 guidance every quarter and is openly priming FY2027 as “another record year.”

The catch is price and timing. PH trades at ~33x trailing GAAP earnings, ~29x forward adjusted EPS, and ~23x EV/EBITDA — every metric at the 95th–96th percentile of its own ten-year history, and at the rich end of an already re-rated multi-industrial peer group. A reverse-DCF implies the market is underwriting ~12% free-cash-flow growth for a decade from a company that grows organically 4–6%; the gap can only be closed by continued margin expansion, perpetual accretive M&A, and a multiple that never reverts. Two further tensions compound the setup: aerospace margins at 29.5% are plausibly a cyclical/mix high rather than a floor, and the newly announced $9.25B Filtration Group acquisition — struck at a full 19.6x EBITDA and levering the balance sheet back toward 3.0x — carries the thinnest synergy margin-of-safety of PH’s recent deal sequence.

This memo argues that PH is a high-quality compounder with a real, financially-visible moat and a best-in-class capital-allocation record — and that the current price already capitalizes most of that quality, leaving an unattractive risk/reward at ~$900. The body takes no position; the falsification tests below frame what would resolve the central debate.

2. Business Overview

Parker-Hannifin designs, manufactures and provides aftermarket support for motion-and-control components and systems. The company describes itself as “the global leader in motion and control technologies,” spanning eight core technology platforms. The business is run through a deliberately decentralized structure of roughly 85 divisions, each with a general manager holding full P&L responsibility — a structure management credits for accountability and the speed of the Win Strategy rollout (Q4 FY2025 call, 2025-08-07). The company was founded in 1917, employs ~57,950 people, and is headquartered in Cleveland, Ohio.

Segment structure (FY2025). PH reports two segments:

(Source: FY2025 10-K, Note 19, Business Segment Information. Total segment operating income reconciles to consolidated operating income of $4,347M after ~$214M corporate G&A.)

Diversified Industrial sells motion-control components — valves, pumps, actuators, hydraulics, pneumatics, filters, fittings, seals, instrumentation — into in-plant/industrial equipment, off-highway (construction, agriculture, mining), transportation, energy, and HVAC/refrigeration end markets, across North America and International (EMEA, Asia-Pacific, Latin America). The critical structural feature is the channel: management states that ~50% of industrial sales flow through independent distributors that serve the MRO/aftermarket replacement market and carry 10–15 margin points more than the direct-OEM business (Morgan Stanley Laguna conference, 2025-09-10). This distribution density — “the envy of the competition,” built over “60–70 years” — is the load-bearing element of the industrial moat (see the Competitive Position section).

Aerospace Systems supplies hydraulic, fuel, pneumatic, electrical, fluid-conveyance, actuation, wheels-and-brakes, fire-protection and sensing content for commercial and military airframes and engines. Following Meggitt, this segment has roughly tripled from ~$2.5B revenue (FY2019/FY2022) to $6.2B (FY2025). Its defining economic feature is the aftermarket annuity: components spec’d onto a platform generate 20–30 years of higher-margin replacement and overhaul revenue. FY2025 closed at roughly 51% aftermarket / 49% OEM, and segment margin reached a record 29.5% in Q3 FY2026.

Revenue quality / recurring mix. Management states roughly two-thirds of total revenue is now longer-cycle, secular or aftermarket, and targets ~85% by FY2029. Backlog stood at a record $12.5B at Q3 FY2026 (aerospace $8.4B, >100% coverage). The mix shift — via CLARCOR, LORD, Meggitt, Curtis and the pending Filtration Group deal — is real and corroborated by the segment-margin record, not merely a narrative.

End-market diversification. Within Diversified Industrial, no single end market dominates: in-plant/industrial equipment, off-highway (construction, agriculture, mining), transportation (heavy-truck, automotive), energy (power generation, oil & gas), and HVAC/refrigeration each contribute meaningfully, spread across North America (~half of industrial) and International. This breadth is a genuine risk-diffuser — in FY2025–FY2026, weakness in agriculture and automotive was offset by strength in power generation, aerospace and in-plant automation. The eight core technologies (hydraulics, pneumatics, electromechanical, filtration, fluid & gas handling, process control, engineered materials, climate control) are deliberately interconnected at the application level, which is what lets a single distributor or OEM specify a multi-technology Parker solution — the commercial logic behind the breadth.

Verdict. A high-quality, well-diversified industrial-plus-aerospace franchise whose revenue base has been deliberately re-weighted toward recurring aftermarket and secular end markets. The distribution channel and the aerospace annuity are the two economically distinctive features; the rest is a broad, competent, but individually-contestable component portfolio. Business model: sound and improving.

3. Industry Dynamics

Structure. Motion-and-control is a highly fragmented industry. PH’s own 10-K is explicit: “we have hundreds of competitors across our various markets… no single competitor competes with the Company with respect to all the products we offer.” PH is the #1 broad-line player by breadth, but in any single product line it faces specialized rivals — Eaton and Bosch Rexroth in hydraulics, Danfoss/Sauer-Danfoss in mobile hydraulics, SMC and Festo in pneumatics, Donaldson in filtration. This is the classic Greenwald “many ants, one anteater” structure: there is no scale monopoly in any individual product, and PH’s edge comes from aggregating eight technologies through a single channel rather than dominating any one of them.

Profit pools. The pools differ sharply in quality:

• Aerospace aftermarket — the most structurally attractive pool PH touches. Sole-source spec positions on engine and airframe platforms generate multi-decade, high-margin annuities largely insulated from new-aircraft order cyclicality (the installed base must be maintained regardless). Rising narrowbody/widebody build rates and air-traffic growth drive both OE and aftermarket. This is genuinely good real estate.
• Industrial motion-control — structurally average-to-good: fragmented, cyclical, low-secular-growth, but with meaningful switching costs at the spec-in and MRO levels. Paradoxically, the low secular growth favors PH’s scale advantage — in Greenwald’s framing, market growth is the enemy of economies of scale, and a slow-growth industry keeps the fixed-cost leverage and channel density defensible.

Capital-cycle position (Marathon lens). Industrial distribution sits in a mid-cycle/early-recovery position: through FY2024–FY2025 the channel worked through a destocking period, and by FY2026 management describes the short-cycle businesses inflecting positive across all three technology platforms for the first time since mid-2023, with orders outpacing sales for ~8 consecutive quarters. There is no evidence of a negative capital cycle — no capacity over-build, capex disciplined at ~2.2% of sales, no rash of new entrants. Aerospace is in a mid-to-late expansion (record backlog, rising build rates). The risk is the inverse: a group-wide valuation peak even as the industrial volume cycle is only mid-recovery.

Competitive intensity & barriers. Barriers in any single product are modest (this is not semiconductors). The durable barriers are at the system level: the breadth of catalog that lets a distributor source interconnected technologies from one supplier; the application-engineering relationships that designed-in PH content; and — in aerospace — the certification and sole-source spec positions that make requalification costly. Regulation is a tailwind in aerospace (certification raises barriers) and largely neutral elsewhere.

Verdict: a good industry position assembled out of mostly mediocre individual markets. The aerospace aftermarket is a genuinely attractive pool; industrial motion-control is fragmented and cyclical but defensible at scale. The structural attractiveness PH enjoys derives from aggregation and channel, not from the inherent economics of any one product line. Structurally above-average — but not a naturally high-return industry absent PH’s scale.

4. Competitive Position

PH’s moat, in Greenwald’s taxonomy, is economies of scale combined with customer captivity, expressed through three reinforcing layers. The test that matters — would the financials deteriorate without it? — is answered affirmatively and quantifiably below.

Layer 1 — Distribution density + breadth-of-catalog (the primary industrial moat). Roughly half of Diversified Industrial revenue flows through an independent distributor network that management describes as the company’s hardest-to-replicate asset: built over 60-plus years, “the envy of the competition,” with distributors acting as “an extension of our engineering teams.” The captivity mechanism is an agency-relationship dynamic: the distributor (not the end-user) selects the part, prefers PH for the breadth that lets it source interconnected technologies from one supplier and for the higher margin PH’s products carry, and the small/mid OEM relies on the distributor’s application expertise. This is a switching cost at the channel and spec-in level, not a true network effect (there is no user-to-user externality — a point worth pressure-testing rather than accepting the “network” label). The financial proof is direct: distribution carries 10–15 margin points more than OEM, and ~50% of industrial revenue runs through it. That spread is the moat made visible in the P&L; remove the channel and industrial margins compress toward the lower OEM level.

Layer 2 — Spec-in switching costs. Approximately 85% of PH products are IP-covered, and application engineers design components into customer systems, after which requalifying an alternative is costly and risky for a part that is a small fraction of total system cost but high cost-of-failure. Notably, the 10-K states PH does not depend on any single patent — confirming the moat is aggregate breadth + designed-in position, the durable kind, rather than patent protection (which Greenwald rates the weakest barrier).

Layer 3 — Aerospace sole-source annuity. Sole-source spec positions on engine/airframe platforms generate 20–30-year aftermarket streams at ~29% margins — the highest-quality captivity PH owns, structurally similar to the Honeywell Aerospace / RTX aftermarket model, and materially deepened by Meggitt’s wheels/brakes, fuel, fire-protection and sensing franchises.

The Win Strategy 3.0 — operating system, not a moat. Management credits the Win Strategy for ~700bps of industrial margin expansion (FY2019 → FY2026 guide) and a ~940bps aerospace margin transformation. This is genuinely impressive execution and a real margin-durability mechanism — PH expanded margins through negative-organic-growth quarters, which is rare. But it must be classified correctly: Greenwald is explicit that good management is emulable and is not itself a competitive advantage. The Win Strategy widens and defends the moat’s financial expression; it does not create the moat. Treat the 700bps as evidence of execution quality, not of structural barrier.

Pressure test — does the moat show up in returns? Yes:

• Diversified Industrial earns ~19.6% operating income on segment assets; Aerospace ~11.8% (lower because Meggitt goodwill inflates the asset base). Industrial’s ~20% is franchise-grade.
• Consolidated ROE ~26% and sustained ~23% segment margins are inconsistent with a no-moat commodity manufacturer (Greenwald’s no-advantage benchmark is ~6–8% ROIC).
• Market-share-stability test: PH has held the #1 broad-line motion-control position for decades — it passes.
• Disconfirming evidence, weighed honestly: in any single product line PH does not dominate. Strip away distribution breadth and the aero annuity and you have a collection of share-takeable component businesses. The moat lives in aggregation and the channel, not in product-level dominance.

Peer comparison. Against ETN, EMR, ITW, DOV, AME and Honeywell Aerospace, PH’s moat is second-tier-to-first-tier. ITW and AMETEK arguably have cleaner operating-system / niche-captivity moats; Honeywell has a better-established aero annuity. But PH’s distribution channel is genuinely differentiated and not quickly buyable by peers, and its aero franchise has moved up to roughly peer-grade post-Meggitt.

The read: PH’s distribution channel is the one moat asset in this set that competitors cannot quickly buy or replicate, and the post-Meggitt aerospace franchise has closed most of the gap to Honeywell. What PH lacks relative to ITW/AMETEK is a single-product dominance — its advantage is portfolio-and-channel aggregation, which is durable but more exposed to slow secular erosion (digital procurement) than a pure niche monopoly.

Verdict: a real, durable, financially-visible moat — scale economies + customer captivity — anchored in the distribution network and the aerospace sole-source annuity, with the Win Strategy as a best-in-class margin-defense layer on top. The honest caveat: the moat’s softest flank is digital procurement disintermediation of the distribution channel, and the durable core would not survive disaggregation of the portfolio. Durable advantage: yes — but earned through aggregation, not product monopoly.

5. Growth History and Forward Opportunities

Historical revenue. FY2021 $14,348M → FY2022 $15,862M (+10.5%) → FY2023 $19,065M (+20.2%) → FY2024 $19,930M (+4.5%) → FY2025 $19,850M (−0.4%). The FY2022→FY2023 step-up is almost entirely Meggitt (closed September 2022, mid-FY2023); aerospace segment sales jumped from $2,520M (FY2022) to $4,360M (FY2023) to $6,185M (FY2025).

Organic vs. acquired — the central honest caveat. PH’s growth algorithm leans heavily on price and M&A, not organic volume. The FY2024→FY2025 flat-to-down headline masks a clear split: aerospace grew +13% (FY2024 $5,472M → FY2025 $6,185M), while Diversified Industrial North America fell ~7.6% as-reported — decomposed in the 10-K as divestitures −3.4%, currency −0.5%, and organic −3.7%. So the soft industrial line was part destocking/weak short-cycle demand and part deliberate portfolio pruning. Management has acknowledged that consolidated volumes are roughly flat ex-acquisitions over a long stretch (Q2 FY2026 call) — meaning the compounding has come from margin expansion, price, mix-shift and accretive M&A rather than unit growth. This is a critical point for the valuation: a 4–6% organic grower is being asked to support a ~29x forward multiple via levers other than volume.

Recent re-acceleration. Q3 FY2026 (ended March 2026) showed +10.6% reported / +6.5% organic growth, record $5.5B sales, with aerospace +14.2% organic and industrial North America +3% (record 25.3% margin). Orders rose +9%; backlog hit a record $12.5B; orders have outpaced sales for ~8 straight quarters — a setup for FY2027 conversion that management is openly priming as “another record year.”

Forward opportunities. (1) Industrial short-cycle inflection — the single most important driver: converting the record long-cycle backlog and “gradual recovery” into accelerating organic growth in FY2027. (2) Aerospace — four consecutive years of double-digit organic growth, record $8.4B backlog, FY2026 guide raised to ~12%; commercial OEM +22%, aftermarket +14% in Q3. (3) Secular adjacencies — electrification (Curtis Instruments bolt-on), data-center thermal (~1% of sales “growing like a weed”), filtration/life-sciences (Filtration Group). (4) Reshoring — framed as a tailwind for MRO and capex through distribution. (5) Margin-led EPS — the >10% adjusted-EPS CAGR target is underwritten more by margin and capital deployment than by volume.

Verdict: high-quality but M&A-and-margin-dependent growth. The quality is high (aftermarket mix, pricing power, record backlog), but the organic volume engine remains the unproven leg — a genuine industrial short-cycle upcycle has not yet shown up in the numbers. The growth is real; its durability without continued accretive M&A is the open question.

6. Financial Quality

Margins — the multi-year Win Strategy story. Consolidated gross margin expanded from 28.2% (FY2022) to 33.7% (FY2023) to 36.8% (FY2025); operating margin from 17.2% (FY2021) to 21.9% (FY2025). The segment detail is the real evidence:

• Diversified Industrial: FY2023 26.4% → FY2024 22.0% → FY2025 22.8%. Margin held ~22–23% despite a −3.7% organic volume decline in FY2025 — genuine decremental-margin control.
• Aerospace Systems: FY2023 12.9% (depressed by Meggitt inventory step-up and integration) → FY2024 20.3% → FY2025 23.3% → record 29.5% in Q3 FY2026. This climb is the single largest margin driver of the last three years.

The investable signal here is not the absolute margin but the decremental-margin resilience: PH expanded margins through a down-cycle, which is rare and points to a structurally more durable earnings base than its cyclical history implies. The multi-year segment-margin progression makes the Win Strategy concrete:

*FY2023 aerospace margin was depressed by Meggitt inventory step-up and integration charges in the first full year; the climb to 29.5% reflects synergy capture plus aftermarket mix, not just cyclical tailwind. The Diversified Industrial line is the more telling number — it held ~22–23% through a −3.7% organic volume decline (FY2025), exactly the decremental discipline a cyclical commodity manufacturer cannot deliver.

Cash flow. OCF grew from $2,980M (FY2023) to $3,776M (FY2025); capex is light at ~2.2% of sales (~$435M FY2025); FCF rose to $3,341M (16.8% FCF margin). FCF/net-income conversion was ~95% in FY2025 — down from ~125% in FY2023 — but this is not an earnings-quality deterioration: FY2025 GAAP net income was flattered by a ~$238M pre-tax gain on a Meggitt-business divestiture and lower interest expense, so net income grew faster than cash. Excluding the one-time gain, conversion remains ~100%+. Cash generation is genuinely strong.

Returns on capital. ROE rose to ~25.8% (FY2025), but is partly leverage- and buyback-flattered (equity is held down by years of repurchases). All-in ROIC (with goodwill) is ~16.6% — solidly above any reasonable WACC. The striking figure: ROIC ex-goodwill/intangibles is ~84% — the underlying operating business earns spectacular returns on tangible capital, and the gap to the ~17% all-in figure is the precise quantification of how much PH has paid up for acquired growth. For an acquirer that will keep deploying capital at full prices, the all-in ~17% is the honest number.

Balance sheet. Total debt ~$9.3B against cash ~$0.47B → net debt ~$8.8B; net debt/EBITDA ~1.68x at FY2025 (down from a post-Meggitt peak ~$11.7B gross debt). Interest coverage ~10.6x; interest expense fell from $574M (FY2023) to $409M (FY2025) on deleveraging. The defining balance-sheet feature — and risk — is intangibility: goodwill + intangibles of ~$18.1B equal ~61% of total assets and ~132% of equity, so tangible book is negative. PH has not taken material goodwill impairments historically, but equity is more than fully composed of acquisition premia.

Quality of earnings. The GAAP-vs-adjusted gap is driven almost entirely by acquisition intangible amortization (~$553M pre-tax FY2025, ~$3.65/share after-tax). This is a non-cash charge, so adjusted EPS is defensible on a cash basis — but the addback also overstates owner-economics, because that ~$3.65/share is the recurring real cost of a serial-M&A strategy PH will keep incurring. SBC is modest (~$159M, ~0.8% of sales). Business-realignment/integration charges (~$56M + ~$31M FY2025) are a perennial “one-time” line and treating them as fully non-recurring is generous. The cleanest lens is cash flow, and it is strong. Net read: GAAP EPS understates cash earnings; adjusted EPS slightly overstates true economics; the truth sits between, closer to the cash figure.

Verdict: economics clearly improve with scale, and earnings quality is good-to-very-good — light capex, strong cash conversion, high tangible returns, conservative leverage. The asterisks are the goodwill-heavy (negative-tangible-book) balance sheet and the recurring amortization that adjusted EPS papers over.

7. Capital Allocation

Five-year deployment (FY2021–FY2025). Of ~$13.5B cumulative FCF, ~$7.1B went to one acquisition (Meggitt, FY2023), ~$3.4B to dividends, ~$3.1B to buybacks, and ~$1.3B net to debt paydown. The hierarchy matches PH’s stated “disciplined, active and balanced” framework: fund organic growth and the dividend first, then M&A, then opportunistic buybacks. After the FY2022 debt raise to pre-fund Meggitt, FY2023–FY2025 was dominated by repaying ~$6.5B of debt.

(Source: PH 10-K cash-flow statements, EDGAR XBRL.) The picture is textbook for a disciplined deleveraging acquirer: operating cash flow grew ~47% over five years on essentially flat capex, the one large acquisition was rapidly de-levered, the dividend compounded ~16%/year, and buybacks flexed up only in the record-FCF FY2025.

M&A track record — value-creating, not empire-building. The evidence favors PH:

• CLARCOR (2017, ~$4.3B) — the filtration template, repeatedly cited as the integration “playbook.”
• LORD + Exotic Metals (2019, ~$3.7B + ~$1.7B) — engineered materials and aerospace.
• Meggitt (September 2022, ~$8.8B) — the clearest value-creation proof point: aerospace sales ~2.5x, ~940bps of segment-margin expansion, and deleveraging to the 2x target in seven quarters. This is the strongest single piece of evidence that the model compounds per-share value rather than merely adding revenue.
• Curtis Instruments (September 2025) — low-voltage motor-control bolt-on for electrification.

The caveat: each deal adds goodwill that depresses headline ROIC, so the value-creation case rests on cash returns and synergy realization, not reported ROIC. PH’s own admission that Filtration Group earns only “high-single-digit ROIC by year 5” is the honest acknowledgment that these deals are dilutive to returns until synergies mature.

Filtration Group (announced November 2025). $9.25B cash; ~$2.0B revenue at 23.5% adjusted EBITDA margin; 85% aftermarket mix; 19.6x headline EBITDA / 13.4x synergized; $220M cost synergies (~11% of sales) over three years plus ~$140M NPV tax benefit. Funded with $5B+ delayed-draw term loans (entered December 2025), levering to ~3.0x net debt/EBITDA at close, with a targeted return to 2.0x in six quarters. Strategically it doubles the CLARCOR filtration franchise into a ~$5B combined business — high-recurring, low-cyclicality, low-capex. The honest read: 19.6x is a full price for a private auction asset, and the deal only works if PH delivers the entire $220M of synergies on an already-well-run business (an analyst on the M&A call pointedly challenged exactly this). This is the deal in the sequence with the thinnest margin of safety.

Dividend & buybacks. PH raised its dividend for a 70th consecutive year in April 2026 (+11% to $2.00/quarter) — among the longest streaks on the NYSE — at a conservative ~23% FCF payout, leaving ample room to sustain the streak through the Filtration leverage spike. Buybacks are opportunistic: $219–460M/year FY2021–2024, spiking to ~$1.77B in FY2025 (record FCF, no large deal pending), and continuing at ~$0.8–1.0B FY2026 YTD. Buying back stock while pre-funding a $9.25B deal and levering to 3.0x is a mild capital-allocation tension worth watching.

Incentive alignment. Correcting a common assumption: PH no longer uses an EVA-based plan. Current metrics — annual cash incentive on segment operating income, revenue, and cash-flow margin (paid 139% of target FY2025); long-term incentive on revenue growth, EPS growth, and growth in average ROIC. Embedding ROIC growth and cash-flow margin directly disciplines the serial-acquisition model — materially better than a pure revenue/EPS scheme. CEO Jenny Parmentier (CEO since January 2023) earned ~$19.3M FY2025, heavily equity-weighted, against a 6x-salary ownership guideline. Insider open-market buying is minimal — only three “P”-coded purchases since 2021 (a director’s ~$1.3M well-timed post-Meggitt-dip buy in May 2022); the rest is routine. Neutral, as typical for a mega-cap.

Verdict: management has allocated capital intelligently, with one watch-item. A demonstrated ability to create value from M&A (Meggitt), rapid repeatable deleveraging, a 70-year dividend, conservative payout, and an incentive plan correctly tied to ROIC and cash conversion. The watch-item is the full-price, synergy-dependent Filtration Group deal layered on a re-leveraging balance sheet — the one place where the otherwise-excellent record carries real execution and price risk.

8. Changes and Headwinds — Last Two Years

Recent-events timeline.

• May 2024 — Analyst Investor Day; FY2029 targets set, with management noting it has repeatedly hit prior margin targets years early.
• FY2024–FY2025 — portfolio pruning: several lower-growth, shorter-cycle businesses divested (~2% reported-sales headwind running through Q2 FY2026; the final divestiture-adjustment quarter). Meggitt integration functionally complete.
• June–September 2025 — Curtis Instruments announced and closed (~$235M sales, electrification bolt-on).
• September 2025 — director Beth Wozniak elected; October — director Joe Scaminace retired.
• November 2025 — Filtration Group acquisition announced ($9.25B); December — term-loan financing entered.
• March 2026 — director Kevin Lobo to not stand for re-election (joining GE HealthCare board; explicitly not a disagreement).
• April 2026 — 70th consecutive annual dividend increase (+11% to $2.00/quarter); Q3 FY2026 record results.

Guidance trajectory — a clean string of beats-and-raises. FY2026 guidance was raised every quarter: organic growth 3.0% → 5.5%; adjusted segment margin 26.5% → 27.2%; adjusted EPS ~$28.90 → ~$31.20 (+14% growth, +8% lift to the guide itself); aerospace organic 8% → 12%. Full-year incrementals were raised from ~35% to ~40%.

End-market color (Q3 FY2026). Aerospace organic +14.2% (commercial OEM +22%, aftermarket +14%, defense OEM +13%), record $8.4B backlog, no slowdown seen. Industrial inflecting positive: North America +3% organic (record 25.3% margin), International +3% (Asia-Pacific +10%, EMEA flat, Latin America down); off-highway raised three times through the year; transportation improving; HVAC/refrigeration and energy positive; data center small but fast-growing. The order-sales gap (8 straight quarters) reflects the shift toward longer-cycle defense/energy/construction bookings.

Tariffs/macro. Management has consistently declined to quantify tariff exposure, asserting a 25-year price/cost “muscle,” local-for-local manufacturing, and dual-sourcing, with “no impact to EPS” — and will not recognize tariff-refund income until received (conservative). The absence of any quantified figure for a global industrial of this size is itself an open question and should be stress-tested against the gross-margin bridges.

Verdict: the last two years strengthen the bull case — record margins/EPS/backlog despite a two-year industrial down-cycle is direct evidence the portfolio is structurally less cyclical and the Win Strategy expands margins through the trough. The countervailing headwinds — the full-price Filtration deal, re-leveraging to 3.0x, growing aerospace concentration (now the dominant growth driver), and an as-yet-unproven industrial volume upcycle — temper but do not reverse that conclusion.

9. Risk Analysis (Risk Matrix)

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation appear in this section. The analysis frames what the current price requires.

Current multiples (2026-06-12, EV ~$123.0B).

Every metric sits at the 95th–96th percentile of PH’s own ten-year history. PH spent most of the 2010s at ~15–18x earnings; the multiple has roughly doubled. That re-rating — not earnings growth alone — has done much of the heavy lifting in the stock’s compounding, and is the central valuation risk.

Peer context. PH sits at the rich end, but not the richest, of the multi-industrial group.

(Source: yfinance, recomputed 2026-06-12; ROP/HON GAAP trailing figures are aggregator artifacts — use forward columns.) On EV/EBITDA (~23x) PH trails only Eaton (~27x) and sits level with AMETEK (~22x); on forward P/E (~26–29x) it is again top-tier, above ITW/DOV/EMR (~19–21x). The most telling comparison is to ITW — the recognized quality benchmark at ~17x EV/EBITDA — over which PH now commands ~5–6 turns. The premium is partly justified by PH’s aero mix and margin profile, but it is layered on top of a group-wide re-rating to levels historically associated with cyclical peaks — effectively double-counting quality. The bull must believe both that PH deserves a premium within the group and that the group itself is not at a cyclical-multiple peak.

Embedded expectations (reverse-DCF). A single-stage Gordon model at an 8.5% WACC implies the EV embeds ~5.6% perpetual FCF growth — aggressive for a mature industrial but not absurd given the margin and M&A levers. A two-stage model (10-year high-growth fade to 3% terminal, 8.5% WACC) implies the market is underwriting ~11–12% FCF CAGR for a decade — far above the 4–6% organic revenue growth rate. The gap must be closed by margin expansion to the FY2029 27% target, continued accretive M&A, and buybacks. In effect, the price treats PH’s FY2029 targets (27% segment margin, >10% adjusted-EPS CAGR, 17% FCF margin, >$18B cumulative five-year FCF, ~85% longer-cycle/aftermarket mix) as a floor, not a stretch goal — requiring margin expansion and perpetual accretive M&A and no multiple reversion, all at once.

Value decomposition. The aerospace annuity (~31% of revenue, 23%+ margin, record 29.5% in Q3) plausibly carries a 25–30%+ slice of EV at an aero-quality multiple — defensible. The industrial recovery is the cyclical swing factor and is not yet in the organic numbers. The M&A engine (Filtration at 19.6x/13.4x synergized) is the biggest leap of faith: the price extrapolates PH’s “buy-high, delever, expand-margin” template into perpetuity.

Scenario analysis (FY2026→FY2029, intrinsic-value zones, explicitly NOT a price target). Anchored on adjusted EPS (~$31.20 FY2026 base) × an exit multiple.

The asymmetry is the point. The bear case — a de-rate to a still-above-historical 20x with margins normalizing — costs ~22%; a true mean-reversion toward ~17x with flat EPS would be ~−35%. The base case (targets met) earns only a market-like ~6%/year because so much is already priced. The investor is paid like a bull only if the bull occurs, and the bull requires peak aero margins to persist while an industrial upcycle simultaneously arrives. Margin of safety at ~$900 is thin.

11. Variant Perception

Consensus view. PH has structurally transformed — the aerospace/aftermarket mix shift plus the Win Strategy operating system have made it a higher-quality, less-cyclical compounder that deserves a permanent re-rating to the mid-/high-20s P/E. The Street underwrites the FY2029 targets as credible and PH as a reliably accretive serial acquirer; the 95th-percentile own-history multiple is accepted as the “new normal.”

Strongest bull case. Aerospace is a multi-decade annuity (record 29.5% margins, record backlog); industrial is at a cyclical trough, not a peak (destocking ending, orders > sales for 8 quarters); the Win Strategy drives the 27% segment-margin target; the M&A flywheel keeps compounding EPS double-digit; and the ~85% longer-cycle/aftermarket mix structurally lowers cyclicality, justifying a permanent premium-to-history multiple.

Strongest bear case. PH is a late-cycle industrial trading at a peak multiple and peak aero margins simultaneously. 33x trailing for a 4–6% organic grower is defensible only via perpetual flawless M&A and margin expansion. Aero margins at 29.5% are a cycle/mix high, not a floor. Net debt plus the $9.25B Filtration deal lifts leverage to ~3.0x, consuming the financial flexibility the multiple assumes. A de-rate toward even 22–24x with any earnings stumble is a 20–35% drawdown.

The 3–5 assumptions that matter most: (1) aero margin durability — is 29.5% a peak or a base?; (2) multiple permanence — does the high-20s P/E hold or revert toward 15–18x?; (3) industrial cycle position — trough (restock coming) or late-cycle (rollover coming)?; (4) M&A-accretion durability — does the Filtration-style flywheel keep adding double-digit EPS, or do full prices (19.6x) and leverage (3.0x) cap it?; (5) FY2029 targets — floor or stretch? The price treats them as a floor.

Falsification. Kills the bull: aero-margin compression off the 29.5% peak; industrial organic growth failing to inflect post-destocking; Filtration synergies slipping / leverage staying >2.5x and crowding out buybacks; any guide-down on the FY2029 margin target. Kills the bear: sustained/expanding aero margins with growing backlog; industrial organic growth re-accelerating to mid-single-digits+; rapid Filtration deleveraging with on-track synergies; the multiple holding through a soft patch (proving the re-rating is structural, not cyclical).

12. Fact vs. Interpretation Table

13. Open Questions

1. Is the 29.5% aerospace segment margin a sustainable base or a cyclical/mix peak? The most important single unknown for the thesis.
2. Will the industrial short-cycle volume inflection actually arrive in FY2027, converting the record backlog into accelerating organic growth — or is the record book a function of longer-cycle bookings that convert slowly?
3. Will the $220M Filtration Group synergies (11% of sales) fully materialize on an already-well-run private asset, and does the deal hit its >30% EBITDA-margin / high-single-digit-ROIC-by-year-5 targets?
4. What is normalized cash ROIC ex-goodwill versus reported ROIC over a full cycle — i.e., does the acquisition flywheel genuinely compound per-share value at the prices now being paid (19.6x)?
5. What is PH’s actual quantified tariff exposure? The blanket “no EPS impact” claim is unverified and unusual for a global industrial of this size.
6. Does continued buyback activity during the post-Filtration deleveraging window strain the six-quarter return-to-2.0x target, or will repurchases throttle as expected?
7. Names and proceeds of the FY2024–FY2025 divestitures (the ~2% reported-sales headwind) — to be reconciled precisely against the 10-K.

14. What Must Be True

Bull case — what must be true: (1) the aerospace aftermarket annuity sustains ~27–29%+ segment margins as a base with the installed base and backlog continuing to grow; (2) the industrial short-cycle inflects positively in FY2027, lifting organic growth to mid-single-digits+; (3) the Win Strategy delivers the 27% segment-margin target on schedule (PH’s pattern of hitting targets early supports this); (4) the M&A flywheel — Filtration and successors — remains EPS-accretive and deleverages on plan; (5) the market continues to award a high-20s multiple, treating the re-rating as structural.

Falsification test (bull): if, over the next 2–4 quarters, aerospace segment margin compresses sequentially off the ~29.5% peak and industrial organic growth fails to accelerate beyond low-single-digits after destocking ends, the “structurally less cyclical compounder” thesis is broken and the premium multiple is unjustified.

Bear case — what must be true: (1) the high-20s multiple mean-reverts toward PH’s 15–18x history as the group-wide industrial re-rating unwinds; (2) aerospace margins normalize off a cyclical/mix peak; (3) the industrial volume upcycle disappoints, exposing the M&A-and-price dependence of the growth algorithm; (4) Filtration synergies disappoint and/or leverage stays elevated, crowding out the buyback/M&A engine the multiple assumes.

Falsification test (bear): if PH sustains or expands aerospace margins with a growing backlog, re-accelerates industrial organic growth to mid-single-digits+, deleverages Filtration on plan with on-track synergies, and the multiple holds through a soft patch, then the re-rating is structural — not cyclical — and the bear’s mean-reversion thesis is wrong.

15. Source Appendix

See the separate Source Appendix (Appendix B in the combined report) for the full citation list. Primary sources: Parker-Hannifin FY2021–FY2025 Forms 10-K and FY2026 10-Qs (SEC EDGAR, CIK 0000076334); FY2025 DEF 14A; Q1–Q4 FY2025 and Q1–Q3 FY2026 earnings-call transcripts; the Filtration Group M&A call (2025-11-11); the May 2024 Analyst Investor Day; SEC EDGAR XBRL financial concepts; and public peer data for ETN, EMR, ITW, DOV, AME, ROP and HON.

This article discusses valuation only as embedded expectations and scenarios; it contains no investment recommendation and no price target except within the clearly-labeled Claude’s Take block. Management commentary is treated as hypothesis and validated against filings and financial outcomes wherever possible. This is general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

Parker-Hannifin Corporation (NYSE: PH) — Standard Diligence Questionnaire

Supplemental diligence questionnaire. Fact / Interpretation / Assumption labels applied where it matters.

General

What thoughtful questions have other investors asked about this company? On the earnings and M&A calls, sophisticated analysts (Vertical, Goldman, Morgan Stanley) pressed on: (1) whether the Filtration Group $220M synergy target (~11% of sales) is realistic for an already-well-run private asset versus the bloated-public-cost-base Meggitt situation — the single sharpest pushback; (2) the durability of the record aerospace margin and aftermarket strength; (3) the unusually long run of orders exceeding sales (~8 quarters) and when it converts to organic growth; (4) the pace of the industrial short-cycle recovery (“gradual” recovery, selective customer capex); and (5) capital-allocation priorities (buybacks vs deleveraging) into the Filtration close. These are the right questions — they map directly to the falsification tests.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: mixed, leaning toward a high. Aerospace margins (29.5% Q3 FY2026) are at a cyclical/mix peak; industrial is recovering off a destocking trough (FY2025 organic −3.7% in North America). Consolidated, the blend is closer to a high than a low because aerospace — now the dominant earnings driver — is at peak profitability while industrial is only mid-recovery.

Driven by the external environment or internal actions? Both. Internal: the Win Strategy operating system drove ~700bps of industrial and ~940bps of aerospace margin expansion and held margins through a down-cycle (decremental-margin control) — a genuine internal lever. External: aerospace build rates, air-traffic recovery, and the industrial destocking/restocking cycle are environmental.

How stable are revenues? Improving. ~Two-thirds of revenue is now longer-cycle/secular/aftermarket (target ~85% by FY2029); record backlog $12.5B with >100% aerospace coverage. But ~69% of revenue is still in cyclical industrial end markets, so volumes swing even as margins are defended.

Outlook for products/services? Solid. Aerospace: four years of double-digit organic growth, record backlog, FY2026 guide ~12%. Industrial: inflecting positive across all three technology platforms for the first time since mid-2023.

How big is this market — growing, shrinking, domestic or international? Large, fragmented, global (North America ~half, plus EMEA/Asia-Pacific/Latin America). Low-secular-growth in core motion-control (which favors PH’s scale), higher-growth in aerospace aftermarket, filtration/life-sciences, electrification and data-center thermal.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Roughly stable; fragmented with hundreds of competitors and no single rival across PH’s full range. Digital/direct procurement is a slow-building competitive pressure on the distribution channel.

How profitable is the business (ROIC, ROE)? ROE ~25.8% (FY2025); all-in ROIC (with goodwill) ~16.6%; ROIC ex-goodwill ~84%. Segment operating margin ~23%. Franchise-grade returns; the ~17% all-in ROIC reflects the goodwill drag from serial M&A.

How profitable is the industry — competitors, barriers? Individual product markets are average-profitability and contestable; the system-level barriers (catalog breadth, distribution density, application-engineering spec-in, aerospace certification/sole-source) are what let PH earn franchise economics. Barriers to entry are high at the portfolio/channel level, modest at the single-product level.

Can the business be easily understood? Yes at a high level (motion-control components + aerospace), though the 85-division, eight-technology breadth makes granular modeling complex.

Can it be undermined by foreign low-cost labor? Limited risk: products are engineered, mission-critical, often low cost-of-purchase / high cost-of-failure, and frequently sole-source-spec’d or certified — not commodity manufacturing. Local-for-local footprint mitigates trade exposure.

Do brands matter? Less as consumer brand, more as a trusted-engineering reputation and the Parker name within the distributor channel — which functions as a quasi-brand among specifiers.

What is the nature of competition? Breadth, application engineering, distribution availability, and (in aerospace) certified content — not primarily price.

Customers’ switching costs? Real at the spec-in/requalification level (industrial) and very high in aerospace (recertifying a component on a flying platform). The 10–15pt distribution-margin premium quantifies the channel captivity.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The distribution network and the aerospace installed-base aftermarket annuity are economically valuable but not capitalized — genuine off-balance-sheet intangible value.

Off-balance-sheet liabilities? Pension obligations (being de-risked, not flagged as materially underfunded); operating leases; standard contingencies. Nothing thesis-driving disclosed.

How conservative is the accounting? Reasonably conservative: light capex, ~95–100%+ cash conversion, modest SBC (~0.8% of sales), and a stated policy not to recognize tariff-refund income until received. The one caveat: recurring “business-realignment/integration” charges treated as one-time, and adjusted EPS that adds back ~$3.65/share of recurring acquisition amortization.

How CapEx-hungry is the business? Low — capex ~2.2% of sales. This is a cash-generative, asset-light-ish industrial.

Capital Allocation & Management

How much FCF, and how is it used? ~$3.34B FCF FY2025 (~$13.5B cumulative over five years). Hierarchy: organic investment + dividend first, then M&A, then opportunistic buybacks. Five-year split: ~$7.1B M&A (Meggitt), ~$3.4B dividends, ~$3.1B buybacks, ~$1.3B net debt paydown.

Significant acquisitions recently? Yes — Curtis Instruments (Sep 2025) and the pending $9.25B Filtration Group (announced Nov 2025), following Meggitt (2022), LORD/Exotic (2019) and CLARCOR (2017). A genuine serial acquirer with a value-creating track record (Meggitt is the proof point) but a full-price latest deal.

Buying back shares? Yes, opportunistically — ~$1.77B FY2025 (record-FCF year), ~$0.8–1.0B FY2026 YTD. Buying back while pre-funding Filtration and levering to 3.0x is a mild tension.

Issuing large amounts of stock to insiders? No — SBC modest (~0.8% of sales); share count managed down via buybacks.

Compensation policy of directors/management? Annual incentive on segment operating income, revenue, and cash-flow margin; long-term incentive on revenue growth, EPS growth, and growth in average ROIC. ROIC- and cash-conversion-linked pay correctly disciplines a serial acquirer. CEO Jenny Parmentier ~$19.3M FY2025, equity-heavy, 6x-salary ownership guideline.

Motivations of management? Well-aligned via ROIC/cash-flow incentives and ownership guidelines; insider open-market buying is minimal (typical for a mega-cap), so alignment rests on the comp design rather than conviction purchases.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — ordinary NYSE-listed US C-corporation common stock; standard 1099 dividend treatment.

Dividend policy? 70 consecutive years of increases (Dividend King); +11% to $2.00/quarter in April 2026; conservative ~23% FCF payout; yield ~0.9% (low — a growth-dividend, not an income name).

How profitable is the business? Very — ~23% segment margins, ~26% ROE, ~17% FCF margin.

Is net income diverging from cash from operations? FY2025 FCF/NI conversion ~95% (down from ~125% FY2023) because GAAP NI was flattered by a ~$238M one-time divestiture gain; excluding it, conversion is ~100%+. No alarming divergence.

Risks & Downside

What factors would cause the stock to decline? A valuation de-rating from the 95th-percentile own-history multiple (the largest risk); aerospace margin normalization off the 29.5% peak; a failed industrial volume recovery; a Filtration synergy/integration shortfall; a broad industrial-cycle rollover.

Risk of a catastrophic loss? Low. Diversified end markets, strong balance sheet (net debt/EBITDA ~1.7x pre-Filtration, ~3.0x post, deleveraging), ~10x interest coverage, and no single-product dependence. The negative-tangible-book (goodwill ~132% of equity) is a vulnerability only in a severe impairment scenario, which has no historical precedent here.

Chance of a total loss? Negligible — a profitable, cash-generative, investment-grade, century-old market leader.

Recent News & Events

Has the business environment changed recently? Yes, favorably on balance: industrial short-cycle inflecting positive after a two-year destocking trough; aerospace at record backlog/margins; FY2026 guidance raised every quarter.

Significant acquisitions? Curtis Instruments (closed Sep 2025); Filtration Group ($9.25B, announced Nov 2025, financing entered Dec 2025).

Change in accounting policies? None material disclosed.

Recent changes — new markets, facilities, management? Portfolio pruning (FY2024–2025 divestitures); board changes (Wozniak added; Scaminace, Lobo departing); 70th consecutive dividend increase (Apr 2026); FY2029 long-range targets set (May 2024).

APPENDIX B — Source Appendix

Parker-Hannifin Corporation (NYSE: PH) — Source Appendix

All sources accessed June 2026 for a report dated 2026-06-13. Primary sources (SEC filings, company transcripts) prioritized over secondary. Management commentary is labeled and treated as hypothesis, validated against filings and financial outcomes where possible.

Primary — SEC Filings (EDGAR, CIK 0000076334)

1. Form 10-K, FY2025 (year ended 2025-06-30), filed 2025-08-22 — business description, segment data (Note 19), MD&A, balance sheet, cash flow, segment margins, divestiture/acquisition disclosures. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000076334
2. Forms 10-K, FY2021–FY2024 — five-year revenue, margin, cash-flow and debt history; Meggitt purchase accounting (FY2023).
3. Form 10-Q, Q3 FY2026 (quarter ended 2026-03-31), filed 2026-05-01 — latest-quarter revenue, segment margins (Aerospace 25.2%/record 29.5% commentary), backlog, Filtration Group disclosure, term-loan financing.
4. Forms 10-Q, Q1–Q2 FY2026 — guidance trajectory, organic growth, Curtis Instruments.
5. DEF 14A (proxy), filed 2025-09-19 — executive compensation metrics (ACIP: segment OI / revenue / cash-flow margin; LTIP: revenue growth / EPS growth / growth in average ROIC), CEO pay, ownership guidelines, peer group.
6. Forms 8-K (2024–2026) — M&A announcements (Filtration Group 2025-11-12; Curtis), term-loan financing (2025-12-10), board changes (Wozniak, Scaminace, Lobo), dividend increases, earnings releases.
7. Forms 3/4/5 (insider transactions, 2021–2026) — ~357 Form 4s reviewed; only three open-market “P” purchases (director J. Wainscott, ~$1.3M, May 2022); balance routine grants/exercises/tax-withholding/sales.
8. SEC EDGAR XBRL financial concepts — RevenueFromContractWithCustomerExcludingAssessedTax, OperatingIncomeLoss, NetIncomeLoss, NetCashProvidedByUsedInOperatingActivities, AdditionsToNoncurrentAssets (capex), Goodwill, IntangibleAssetsNetExcludingGoodwill, LongTermDebtNoncurrent, AmortizationOfIntangibleAssets, ShareBasedCompensation, PaymentsForRepurchaseOfCommonStock, PaymentsOfDividends, EarningsPerShareDiluted.

Primary — Company Transcripts & Investor Materials

9. Q3 FY2026 earnings call, 2026-04-30 — record results, segment margins, backlog $12.5B (aero $8.4B), end-market color, guidance raise, 70th dividend increase, tariff framing.
10. Q2 FY2026 call, 2026-01-29 and Q1 FY2026 call, 2025-11-06 — guidance raises, Curtis close, ex-acquisition volume commentary, FY2027 priming.
11. Q4 FY2025 call, 2025-08-07 — FY2025 results, portfolio-transformation targets (85% longer-cycle by FY2029), distribution-channel commentary, decentralized structure.
12. Filtration Group M&A call, 2025-11-11 — deal terms ($9.25B, 19.6x / 13.4x synergized EBITDA, $220M synergies, ~3.0x leverage, accretion), analyst pushback on synergy realism.
13. Q1–Q3 FY2025 earnings calls (2024-10-31, 2025-01-30, 2025-05-01) — destocking commentary, margin resilience through the down-cycle.
14. Analyst/Investor Day, May 2024 — FY2029 targets (27% segment margin, >10% adj-EPS CAGR, 17% FCF margin, >$18B 5-yr FCF, ~85% longer-cycle/aftermarket mix).
15. Conference presentations (2025) — Morgan Stanley Laguna (2025-09-10): distribution-margin-premium and channel-durability commentary.

Secondary / Quantitative Helpers

16. yfinance (via fetch.py) — live price, market cap, enterprise value, debt/cash, 52-week range, peer multiples (ETN, EMR, ITW, DOV, AME, ROP, HON). Unofficial; reconciled to filings.
17. Public market-data aggregators — sector/GICS classification, employee count, business description, and own-history valuation percentiles (P/E, P/B, P/S at the 95th–96th percentile). Third-party aggregated data; used for orientation only, not as primary authority.

Cross-Read — Prior Internal Same-Sector Reports

18. Peer public filings and disclosures — AMETEK (AME), Eaton (ETN), Amphenol (APH), Illinois Tool Works (ITW), Emerson (EMR), Dover (DOV), Honeywell (HON) — for peer multiple, moat-quality and capital-cycle framing; peer multiples independently recomputed.

Analytical Frameworks

19. Analytical frameworks — Greenwald & Kahn (Competition Demystified): moat-type taxonomy (scale economies + customer captivity), market-share-stability and ROIC tests, EPV. Marathon (Capital Returns): supply-side capital-cycle analysis applied to industrial distribution and aerospace.